1. Risk Factors for Colorectal Cancer Following Breast Cancer

   • Leanne M. Kmet
   • Linda S. Cook
   • Emily White

   OriginalPaper Pages: 143 - 147

2. Higher Stromal Expression of Transforming Growth Factor-beta Type II Receptors is Associated with Poorer Prognosis Breast Tumors

   • John Barlow
   • David Yandell
   • Karen Plaut

   OriginalPaper Pages: 149 - 159

3. Effect of Exogenous Epidermal-Like Growth Factors on Mammary Gland Development and Differentiation in the Estrogen Receptor-Alpha Knockout (ERKO) Mouse

   • Nicholas J. Kenney
   • Arthur Bowman
   • David S. Salomon

   OriginalPaper Pages: 161 - 173

4. Expression of the CCAAT/Enhancer-Binding Proteins C/EBPα, C/EBPβ and C/EBPδ in Breast Cancer: Correlations with Clinicopathologic Parameters and Cell-Cycle Regulatory Proteins

   • Karin Milde-Langosch
   • Thomas Löning
   • Ana-Maria Bamberger

   OriginalPaper Pages: 175 - 185

5. EGFR, HER-2/neu, Cyclin D1, p21 and p53 in Correlation to Cell Proliferation and Steroid Hormone Receptor Status in Ductal Carcinoma in situ of the Breast

   • Annette Lebeau
   • Angela Unholzer
   • Udo Löhrs

   OriginalPaper Pages: 187 - 198

6. Acceptability of Diagnostic Tests for Breast Cancer

   • Wenchi Liang
   • William F. Lawrence
   • Marc E. Lippman

   OriginalPaper Pages: 199 - 206

7. Postmenopausal Women who Progress on Fulvestrant ('Faslodex') Remain Sensitive to Further Endocrine Therapy

   • I. Vergote
   • J.F.R. Robertson
   • L. Mauriac

   OriginalPaper Pages: 207 - 211

8. Hormone Replacement Therapy after Treatment for Breast Cancer: Physicians' Attitudes towards Randomized Trials

   • ME Del Giudice
   • CA Sawka
   • E Franssen

   OriginalPaper Pages: 213 - 223

9. Treatment of Early Stage Breast Cancer: do Surgeons and Patients Agree Regarding Whether Treatment Alternatives were Discussed?

   • Nancy L. Keating
   • Jane C. Weeks
   • Edward Guadagnoli

   OriginalPaper Pages: 225 - 231

10. Effects of Long-Term HRT and Tamoxifen on the Expression of Progesterone Receptors A and B in Breast Tissue from Surgically Postmenopausal Cynomolgus Macaques

    • E. Isaksson
    • H. Wang
    • E. von Schoultz

    OriginalPaper Pages: 233 - 239

11. Prolactin Overexpression by MDA-MB-435 Human Breast Cancer Cells Accelerates Tumor Growth

    • Karen Liby
    • Bonnie Neltner
    • Nira Ben-Jonathan

    OriginalPaper Pages: 241 - 252

12. Phosphocitrate Inhibits Calcium Hydroxyapatite Induced Mitogenesis and Upregulation of Matrix Metalloproteinase-1, Interleukin-1β and Cyclooxygenase-2 mRNA in Human Breast Cancer Cell Lines

    • Michelle M. Cooke
    • Geraldine M. McCarthy
    • Maria P. Morgan

    OriginalPaper Pages: 253 - 263

13. Nutrition and Lifestyle Factors on the Risk of Developing Breast Cancer

    • Bernd Gerber
    • Heiner Müller
    • Klaus Friese

    OriginalPaper Pages: 265 - 276

14. Revised and new SABCS 2002 abstracts

    Legacy Pages: 277 - 277

15. 2. Survival Impact of HER-2/Neu, Cox-2, Urokinase Plasminogen Activator (upa), Cytokeratin 17/5,6 and other Markers with Long-Term Outcome of Early Breast Cancer. Report from the British Columbia Tissue Micro-Array Project (BCTMAP)

    • J. Ragaz
    • M. Lippman
    • D. Hayes

    OriginalPaper Pages: 278 - 278

16. 158. Pathological Complete Response is not the Best Prognostic Factor in Patients with Breast Cancer Treated by Preoperative Chemotherapy

    • A. Honig
    • E.F. Solomayer
    • D. Wallweiner

    OriginalPaper Pages: 279 - 279

17. 290. Phase I Study of Pemetrexed (ALIMTA) and Epirubicin in Patients with Locally Advanced or Metastatic Breast Cancer

    • R. Paridaens
    • L. Dirix
    • H. Dumez

    OriginalPaper Pages: 280 - 280

18. Breast Cancer Research and Treatment

    Instructions for Authors Pages: 281 - 285